Clinical trial
Assessing the Induction of Long-term Immune Regulation Following Treatment With Lemtrada® (Alemtuzumab).
NCT03647722 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessing the Induction of Long-term Immune Regulation Following Treatment With Lemtrada® (Alemtuzumab).
- Lead sponsor
- University of Southern California
- Phase
- Observational
- Overall status
- Terminated
- Start date
- November 2, 2018
- Completion date
- November 30, 2020
- Enrollment
- 97 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.